VANGUARD GROUP INC 13D/13G Filings for Alaunos Therapeutics, Inc. (TCRT)

VANGUARD GROUP INC 13D and 13G filings for Alaunos Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-09
10:54 am
Sale
2022-12-3013GAlaunos Therapeutics, Inc.
TCRT
VANGUARD GROUP INC60,985
3.810%
-16,573decrease
(-21.37%)
Filing
2022-02-10
08:47 am
Sale
2021-12-3113GAlaunos Therapeutics, Inc.
TCRT
VANGUARD GROUP INC77,558
5.380%
-28,905decrease
(-27.15%)
Filing
2021-02-10
12:04 pm
Purchase
2020-12-3113GAlaunos Therapeutics, Inc.
TCRT
VANGUARD GROUP INC106,463
7.450%
22,496increase
(+26.79%)
Filing